|
Renal cell carcinoma |
7 (38.8) |
Nephrectomy (22. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013;95:267-74.) |
|
- Clear cell in native kidney |
5 (27.7) |
Sunitinib (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
|
T1aN0MO, T4N1M1 |
2 (11.1) |
Bilateral RN (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
Renal |
- Bilateral papillary type 1 in native kidney |
2 (11.1) |
|
|
T1aN0MO |
3 (16.6) |
PN (22. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013;95:267-74.) |
|
- Clear cell in kidney graft |
|
RN (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
|
T1aN0M0 (33. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005;80(2 Suppl):S254-64.) |
|
|
Bladder |
Urothelial carcinoma: |
6 (33.3) |
TURB (55. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24:3225-31.) |
|
LG-NIMBC (55. Stewart JH, Vajdic CM, van Leeuwen MT, Amin J, Webster AC, Chapman JR, et al. The pattern of excess cancer in dialysis and transplantation. Nephrol Dial Transplant. 2009;24:3225-31.), Adenocarcinoma (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
5 (27.7) |
Nephrouretectomy (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
|
Upper tract urothelial carcinoma |
1 (5.5) |
Chemotherapy (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
Prostate |
Adenocarcinoma: 7(3+4), 7 (4+3) |
2 (11.1) |
RP (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) ADT (11. Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc. 2011;43:376-9.) |
Penis |
Squamous cell carcinoma: In situ (22. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013;95:267-74.) |
2 (11.1) |
Circumcision (22. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013;95:267-74.) |
GCT |
Non-seminomatous germ cell tumor |
1 (5.5) |
Chemotherapy |